Search for a rare disease
Other search option(s)
Isotretinoin syndrome
Disease definition
A rare tetrogenic embryofetopathy due to exposure to isotretinoin, an oral synthetic vitamin A derivative, which is used to treat severe recalcitrant cystic acne. Exposure to isotretinoin during the first trimester of pregnancy has been associated with an increased risk of spontaneous abortions and severe birth defects including serious craniofacial (microcephaly, asymmetric crying facies, microphthalmia, developmental abnormalities of the external ear, ocular hypertelorism), cardio vascular (conotruncal heart defects, aortic arch abnormalities), and central nervous system (hydrocephalus, microcephaly, lissencephaly, Dandy-Walker malformation, cognitive deficit) anomalies and thymic aplasia.
ORPHA:2305
Classification level: Disorder- Synonym(s):
- Isotretinoin embryopathy
- Retinoic acid embryopathy
- Retinoids embryopathy
- Prevalence: Unknown
- Inheritance: Not applicable
- Age of onset: Infancy, Neonatal
- ICD-10: Q86.8
- ICD-11: LD2F.0Y
- OMIM: -
- UMLS: C2930972
- MeSH: C535670
- GARD: -
- MedDRA: -
A summary on this disease is available in Español (2016) Italiano (2016) Nederlands (2016) Deutsch (2006) Français (2006) Polski ()
Additional information
Further information on this disease
Patient-centred resources for this disease
Research activities on this disease
Specialised Social Services
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.